The use of dry amniotic membrane in pterygium surgery

Gelareh S Noureddin, Sonia N Yeung Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada Abstract: Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Noureddin GS, Yeung SN
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/c8a3b1d1e0894606810132945209a2fa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c8a3b1d1e0894606810132945209a2fa
record_format dspace
spelling oai:doaj.org-article:c8a3b1d1e0894606810132945209a2fa2021-12-02T04:23:39ZThe use of dry amniotic membrane in pterygium surgery1177-5483https://doaj.org/article/c8a3b1d1e0894606810132945209a2fa2016-04-01T00:00:00Zhttps://www.dovepress.com/the-use-of-dry-amniotic-membrane-in-pterygium-surgery-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Gelareh S Noureddin, Sonia N Yeung Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada Abstract: Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conjunctival autografting, and the use of adjuvant therapies. This paper reviews the incidence and prevalence of pterygia and also describes the various techniques currently used to treat this condition. These management options are compared to the use of dry amniotic membrane grafting (AMG), specifically with regard to recurrence rates, time to recurrence, safety and tolerability, as well as patient factors including cosmesis and quality of life. AMG has been used in the treatment of ocular surface disease due to a variety of benefits, including its anti-inflammatory properties, as well as its ability to promote epithelial growth and suppress transforming growth factor-β signaling and fibroblast proliferation. However, rates of recurrence for AMG following pterygium excision still surpass other commonly used techniques, including conjunctival and limbal autografting. Nevertheless, there are circumstances in which AMG may be most beneficial to the patient, such as when preexisting conjunctival scarring is present, when the conjunctiva must be spared for future glaucoma filtering surgery, or in cases of large or double-headed pterygia. Therefore, surgeons should be prepared to offer this procedure as an option to their patients for the treatment of pterygia. Keywords: cornea, pterygium, amniotic membrane, conjunctival autograftNoureddin GSYeung SNDove Medical Pressarticlecorneapterygiumamniotic membraneconjunctival autograftOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 705-712 (2016)
institution DOAJ
collection DOAJ
language EN
topic cornea
pterygium
amniotic membrane
conjunctival autograft
Ophthalmology
RE1-994
spellingShingle cornea
pterygium
amniotic membrane
conjunctival autograft
Ophthalmology
RE1-994
Noureddin GS
Yeung SN
The use of dry amniotic membrane in pterygium surgery
description Gelareh S Noureddin, Sonia N Yeung Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada Abstract: Pterygium is a fibrovascular growth of the bulbar conjunctiva that crosses the limbus and extends over the peripheral cornea, in some cases resulting in significant visual morbidity. When treatment is indicated, surgery is necessary, and several management options exist. These include excision, conjunctival autografting, and the use of adjuvant therapies. This paper reviews the incidence and prevalence of pterygia and also describes the various techniques currently used to treat this condition. These management options are compared to the use of dry amniotic membrane grafting (AMG), specifically with regard to recurrence rates, time to recurrence, safety and tolerability, as well as patient factors including cosmesis and quality of life. AMG has been used in the treatment of ocular surface disease due to a variety of benefits, including its anti-inflammatory properties, as well as its ability to promote epithelial growth and suppress transforming growth factor-β signaling and fibroblast proliferation. However, rates of recurrence for AMG following pterygium excision still surpass other commonly used techniques, including conjunctival and limbal autografting. Nevertheless, there are circumstances in which AMG may be most beneficial to the patient, such as when preexisting conjunctival scarring is present, when the conjunctiva must be spared for future glaucoma filtering surgery, or in cases of large or double-headed pterygia. Therefore, surgeons should be prepared to offer this procedure as an option to their patients for the treatment of pterygia. Keywords: cornea, pterygium, amniotic membrane, conjunctival autograft
format article
author Noureddin GS
Yeung SN
author_facet Noureddin GS
Yeung SN
author_sort Noureddin GS
title The use of dry amniotic membrane in pterygium surgery
title_short The use of dry amniotic membrane in pterygium surgery
title_full The use of dry amniotic membrane in pterygium surgery
title_fullStr The use of dry amniotic membrane in pterygium surgery
title_full_unstemmed The use of dry amniotic membrane in pterygium surgery
title_sort use of dry amniotic membrane in pterygium surgery
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/c8a3b1d1e0894606810132945209a2fa
work_keys_str_mv AT noureddings theuseofdryamnioticmembraneinpterygiumsurgery
AT yeungsn theuseofdryamnioticmembraneinpterygiumsurgery
AT noureddings useofdryamnioticmembraneinpterygiumsurgery
AT yeungsn useofdryamnioticmembraneinpterygiumsurgery
_version_ 1718401273099714560